Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > The floor is $2.71US+ brokers cut
View:
Post by scarlet1967 on Jan 12, 2021 10:55am

The floor is $2.71US+ brokers cut

Giving the size of the offering I doubt these brokers manage to sell all of the equities to one stakeholder hopefully I am wrong as many mentioned a single large holder would bring credibility along with analysts working with them.
Apart from some costs involved to close a deal like this these brokers need to sell the equities with a premium which bring me to the fact it is in their interest for the SP in the next few days. Weeks incorporate that premium.
Point is they ultimately want the SP rise from the bought deal price the higher it gets the more profit for the brokers.
After that the trick is the company keep the new investors convinced to hold on to their position as there is no immediate or medium term need for additional funding and they have two potential very lucrative programs which have promising prospects in 2021 and beyond add to that two commercialized drugs with growing sales.
Comment by scarlet1967 on Jan 12, 2021 11:37am
Advantages to Underwriters The underwriters are able to purchase the offering at a steep discount to market value; and The higher the price that the underwriters are able to resell on the market, the greater the profits realized by the underwriters.     Advantages to Issuer Company The issuer company faces no financing risk; and The issuer company receives funds instantly.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse